Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 08 06 2023
revised: 25 06 2023
accepted: 28 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Neurofibromatosis type 1 is a rare autosomal dominant genetic disorder, with up to 50% of patients clinically displaying skeletal defects. Currently, the pathogenesis of bone disorders in NF1 patients is unclear, and there are no effective preventive and treatment measures. In this study, we found that knockout of the NF1 gene reduced cAMP levels and osteogenic differentiation in an osteoblast model, and icariin activated the cAMP/PKA/CREB pathway to promote osteoblast differentiation of the NF1 gene knockout cell model by increasing intracellular cAMP levels. The PKA selective inhibitor H89 significantly impaired the stimulatory effect of icariin on osteogenesis in the NF1 cell model. In this study, an osteoblast model of NF1 was successfully constructed, and icariin was applied to the cell model for the first time. The results will help to elucidate the molecular mechanism of NF1 bone disease and provide new ideas for the clinical prevention and treatment of NF1 bone disease and drug development in the future.

Identifiants

pubmed: 37446790
pii: molecules28135128
doi: 10.3390/molecules28135128
pmc: PMC10343815
pii:
doi:

Substances chimiques

icariin VNM47R2QSQ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Youth Project of Shandong Provincial Natural Science Foundation
ID : ZR2020QH330
Organisme : Traditional Chinese Medicine Science and Technology Project of Shandong Province
ID : 2020M054

Références

Tissue Eng Part A. 2012 Mar;18(5-6):558-67
pubmed: 21942968
Menopause. 2014 Sep;21(9):1007-16
pubmed: 24552978
Cell Biochem Biophys. 2013 Sep;67(1):189-97
pubmed: 23417569
Biochem Biophys Res Commun. 2008 May 2;369(2):444-8
pubmed: 18295595
J Bone Miner Metab. 2018 Nov;36(6):668-678
pubmed: 29264750
Exp Ther Med. 2016 Jun;11(6):2399-2406
pubmed: 27284327
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7281-6
pubmed: 18490653
Science. 1997 May 2;276(5313):791-4
pubmed: 9115203
Phytomedicine. 2018 Jun 1;45:41-48
pubmed: 29573911
Nat Commun. 2021 Oct 1;12(1):5758
pubmed: 34599173
Cancers (Basel). 2022 Sep 17;14(18):
pubmed: 36139671
Neuroscientist. 2011 Feb;17(1):54-78
pubmed: 20431046
Evid Based Complement Alternat Med. 2013;2013:652317
pubmed: 24348713
Hum Mol Genet. 2007 Apr 15;16(8):874-86
pubmed: 17317783
Osteoporos Int. 2005 Aug;16(8):928-36
pubmed: 15551055
Biomed Pharmacother. 2017 Oct;94:1-9
pubmed: 28742995
Biochem Biophys Res Commun. 2019 May 7;512(3):591-597
pubmed: 30910359
Molecules. 2019 May 15;24(10):
pubmed: 31096652
Molecules. 2019 Oct 28;24(21):
pubmed: 31661767
Am J Med Genet A. 2009 Oct;149A(10):2327-38
pubmed: 19764036
Dev Period Med. 2014 Jul-Sep;18(3):297-306
pubmed: 25182393
Osteoarthritis Cartilage. 2012 Dec;20(12):1647-56
pubmed: 22917745
Hum Mol Genet. 2006 Oct 1;15(19):2837-45
pubmed: 16893911
Phytomedicine. 2021 Oct;91:153680
pubmed: 34352588
Bone. 2002 Sep;31(3):396-401
pubmed: 12231412
Biochimie. 2012 Dec;94(12):2514-22
pubmed: 22796380
Nature. 1977 Dec 22-29;270(5639):725-7
pubmed: 563524
Pharmaceutics. 2020 Mar 02;12(3):
pubmed: 32131534
Phytomedicine. 2014 Oct 15;21(12):1633-7
pubmed: 25442270
Phytother Res. 2012 Sep;26(9):1385-92
pubmed: 22308065
J Bone Miner Res. 2015 Jan;30(1):55-63
pubmed: 25043591
Cell Signal. 2016 Aug;28(8):1048-57
pubmed: 27156839
Cell Metab. 2006 Dec;4(6):441-51
pubmed: 17141628
Orphanet J Rare Dis. 2021 Mar 23;16(1):147
pubmed: 33757576
J Clin Med. 2022 Jan 15;11(2):
pubmed: 35054138
Int J Mol Med. 2012 Oct;30(4):889-95
pubmed: 22842877
Bone. 2009 May;44(5):872-7
pubmed: 19442611
J Biol Chem. 2017 Dec 22;292(51):20883-20896
pubmed: 29089388
Nat Rev Cancer. 2015 May;15(5):290-301
pubmed: 25877329
J Bone Miner Res. 2004 Jun;19(6):983-9
pubmed: 15125795
Molecules. 2011 Dec 06;16(12):10123-33
pubmed: 22146373
Clin Orthop Surg. 2011 Sep;3(3):230-7
pubmed: 21909471
J Neurosci. 2003 Oct 1;23(26):8949-54
pubmed: 14523097
J Med Genet. 2009 Apr;46(4):259-65
pubmed: 19066167
Arch Dermatol Res. 2012 May;304(4):325-31
pubmed: 22120694
Bone. 2021 Nov;152:116060
pubmed: 34144233
Calcif Tissue Int. 2016 Aug;99(2):187-98
pubmed: 27061090
FEBS Lett. 1996 Mar 11;382(1-2):53-9
pubmed: 8612763
Pediatr Res. 2008 Jun;63(6):697-701
pubmed: 18317233
Glia. 2018 Nov;66(11):2487-2502
pubmed: 30306639

Auteurs

Meng Chen (M)

Shandong Center for Disease Control and Prevention, Jinan 250014, China.
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.
Shandong Qidu Pharmaceutical Co., Ltd., Shandong Provincial Key Laboratory of Neuroprotective Drugs, Zibo 255400, China.

Lianhua Lu (L)

Shandong Center for Disease Control and Prevention, Jinan 250014, China.

Dong Cheng (D)

Shandong Center for Disease Control and Prevention, Jinan 250014, China.

Jing Zhang (J)

Shandong Center for Disease Control and Prevention, Jinan 250014, China.

Xinyong Liu (X)

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.

Jianli Zhang (J)

Shandong Qidu Pharmaceutical Co., Ltd., Shandong Provincial Key Laboratory of Neuroprotective Drugs, Zibo 255400, China.

Tianliang Zhang (T)

Shandong Center for Disease Control and Prevention, Jinan 250014, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH